These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14141582)

  • 1. THERMORESISTANCE TESTING FOR IDENTIFICATION OF LSC 2AB VIRUS PROGENY.
    JANDA Z; VONKA V
    Arch Gesamte Virusforsch; 1964; 14():227-37. PubMed ID: 14141582
    [No Abstract]   [Full Text] [Related]  

  • 2. MARKER TEST OF POLIOVIRUS IN RELATION TO MASS VACCINATION WITH LIVE ORAL VACCINES.
    TOYOSHIMA K; MITSUDA B; TADOKORO J; YAMADA T; KUNITA N
    Biken J; 1963 Jul; 6():57-72. PubMed ID: 14147706
    [No Abstract]   [Full Text] [Related]  

  • 3. INTRATYPIC SERODIFFERENTIATION TESTS ON POLIO TYPE 1 VIRUS STRAINS ISOLATED BEFORE AND AFTER VACCINATION WITH ATTENUATED SABIN TYPE 1 POLIO VACCINE.
    HAHNEMANN F; SIBONI K; GODTFREDSEN A
    Acta Pathol Microbiol Scand; 1964; 61():437-45. PubMed ID: 14164891
    [No Abstract]   [Full Text] [Related]  

  • 4. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. I. STUDIES ON TYPE 1 STRAINS.
    FURESZ J; ARMSTRONG RE; YAROSH W; NAGLER FP
    Am J Hyg; 1964 Jul; 80():45-54. PubMed ID: 14192769
    [No Abstract]   [Full Text] [Related]  

  • 5. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. II. STUDIES ON TYPE 3 STRAINS.
    FURESZ J; ARMSTRONG RE; MOREAU P; NAGLER FP
    Am J Hyg; 1964 Jul; 80():55-61. PubMed ID: 14192770
    [No Abstract]   [Full Text] [Related]  

  • 6. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 7. THE TYPING OF ENTEROVIRUSES IN TISSUE CULTURE BY NEUTRALIZATION WITH COMPOSITE ANTISERUM POOLS.
    HAMBLING MH; DAVIS PM; MACRAE AD
    J Hyg (Lond); 1963 Dec; 61(4):479-84. PubMed ID: 14103547
    [No Abstract]   [Full Text] [Related]  

  • 8. ENTEROVIRUS TYPING BY COMPLEMENT FIXATION.
    GNESH GM; PLAGER H; DECHER W
    Proc Soc Exp Biol Med; 1964 Apr; 115():898-900. PubMed ID: 14166601
    [No Abstract]   [Full Text] [Related]  

  • 9. THE USE OF A MODIFIED WECKER TECHNIQUE FOR SERODIFFERENTIATION OF TYPE 1 POLIOVIRUSES RELATED AND UNRELATED TO SABIN'S VACCINE STRAIN. II. ANTIGENIC SEGREGATION OF ISOLATES FROM SPECIMENS COLLECTED IN FIELD STUDIES.
    NAKANO JH; GELFAND HM; COLE JT
    Am J Hyg; 1963 Sep; 78():214-26. PubMed ID: 14063724
    [No Abstract]   [Full Text] [Related]  

  • 10. THE STABILIZING EFFECT OF L-CYSTINE ON THE THERMAL INACTIVATION OF POLIOVIRUS. I. DIFFERENTIATION OF THE STRAINS OF POLIOVIRUS BY HEATING WITH L-CYSTINE.
    IKEGAMI N; YOSHIKAWA E; TAGAYA I
    Jpn J Med Sci Biol; 1963 Dec; 16():325-42. PubMed ID: 14130752
    [No Abstract]   [Full Text] [Related]  

  • 11. ASSAY OF MOUSE ADAPTED DENGUE VIRUSES IN MAMMALIAN CELL CULTURES BY AN INTERFERENCE METHOD.
    HALSTEAD SB; SUKHAVACHANA P; NISALAK A
    Proc Soc Exp Biol Med; 1964 Apr; 115():1062-8. PubMed ID: 14166560
    [No Abstract]   [Full Text] [Related]  

  • 12. CHARACTERISTICS OF SABIN TYPE 1 POLIOVIRUS AFTER GASTROINTESTINAL PASSAGE IN NEWBORN INFANTS. II. ANTIGENICITY AND ELUTION FROM AL(OH)3 GEL.
    WOODS WA; ROBBINS FC; WEISS RA; CASHEL J; KIRSCHSTEIN RL
    Am J Hyg; 1964 Mar; 79():236-44. PubMed ID: 14131876
    [No Abstract]   [Full Text] [Related]  

  • 13. MUTATION TO INCREASED VIRULENCE DURING CHRONIC INFECTION WITH SABIN LSC.2AB TYPE I POLIOVIRUS.
    PAUL SD; HOSKINS JM
    Br J Exp Pathol; 1965 Apr; 46(2):173-82. PubMed ID: 14286946
    [No Abstract]   [Full Text] [Related]  

  • 14. PHOSPHATASE ACTIVITY IN HOMOGENATES FROM NORMAL AND POLIOVIRUS INFECTED TISSUE CULTURES. II. VARIATIONS INDUCED BY INFECTION AND BICARBONATE POISONING.
    DEIG EF; GEBHARDT LP
    Z Naturforsch B; 1963 Nov; 18():912-8. PubMed ID: 14101865
    [No Abstract]   [Full Text] [Related]  

  • 15. A NATIONWIDE SERUM SURVEY OF UNITED STATES MILITARY RECRUITS, 1962. II. POLIOVIRUS ANTIBODY LEVELS.
    NIEDERMAN JC; OPTON EM
    Am J Hyg; 1964 Nov; 80():293-303. PubMed ID: 14225919
    [No Abstract]   [Full Text] [Related]  

  • 16. THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS.
    VONKA V; JANDA Z; SIMON J
    Arch Gesamte Virusforsch; 1964 Jun; 14():599-610. PubMed ID: 14247356
    [No Abstract]   [Full Text] [Related]  

  • 17. REACTION OF POLIOVIRUS AND FORMALDEHYDE IN MAGNESIUM CHLORIDE SOLUTION TO ENHANCE POTENCY OF KILLED-VIRUS VACCINE.
    OZAKI Y; MELNICK JL
    J Immunol; 1963 Mar; 90():429-37. PubMed ID: 14051877
    [No Abstract]   [Full Text] [Related]  

  • 18. PHOTODYNAMIC INACTIVATION OF POLIOVIRUS.
    WALLIS C; MELNICK JL
    Virology; 1963 Nov; 21():332-41. PubMed ID: 14081357
    [No Abstract]   [Full Text] [Related]  

  • 19. PRODUCTION OF HIGH-TITER ENTEROVIRUS ANTISERA IN BABOONS.
    OCAMPO AR; MELNICK JL
    Am J Hyg; 1964 May; 79():349-56. PubMed ID: 14159954
    [No Abstract]   [Full Text] [Related]  

  • 20. ANTIGENIC VARIATIONS AMONG TYPE III POLIOMYELITIS VIRUSES.
    DEIBEL R; MACDONALD D
    N Y State J Med; 1964 Aug; 64():2058-65. PubMed ID: 14180893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.